Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Post-operative Morphine Consumption in Obese Patients Undergoing Laparoscopic Bariatric Surgery Following Ketamina and Lidocaine Perfusion


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05591105

Organisation Name: Tiva Group

Overal Status: Recruiting

Start Date: January 15, 2022

Last Update: November 29, 2022

Lead Sponsor: Tiva Group

Brief Summary: The goal of this observational study is to evaluate the quality of postoperative analgesia in a group of obese patients schedule to bariatric surgery under TIVA Opiod-free after to receive lidocaine and ketamine perfusion. The main question it aims to answer are: How lidocaine and ketamine perfusion during recovery period does impact over morphine consumption on the following 48 hours after surgery? All participants will receive total intravenous anesthesia and, at the end of the surgery, they will be divided in two groups, group A: placebo and, group B: with postoperative lidocaine and ketamine perfusion. Our hypothesis is ketamine and lidocaine are a good alternative to decrease the use of morphine in obese patients.

Conditions:
  • Pharmacological Action
  • Post Operative Pain
  • Opioid Use
  • Obesity, Morbid
  • Anesthesia Morbidity


Total execution time in seconds: 0.18886208534241